Additive Manufacturing Resins Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2031)

Global Additive Manufacturing Resins Market Trends and Insights

Demand for Patient-Specific Medical Components

Personalized medical manufacturing supports long-term demand for the additive manufacturing resins market because clinical parts require defined material performance and controlled production records. International Organization for Standardization (ISO) 10993-series biocompatibility standards increasingly define the qualification threshold for medical resin products, including products intended for repeated patient contact. Stratasys’ P3 MED Silicone 25A is certified against ISO 10993-5, ISO 10993-10, and ISO 10993-23, and it is supported by a Food and Drug Administration (FDA) Master File for patient-specific wearable medical devices^{[1]Stratasys, “P3 MED Silicone 25A Biocompatible Silicone for Medical 3D Printing,” Stratasys, stratasys.com}. FDA and European Union Medical Device Regulation (EU MDR) post-market surveillance requirements favor suppliers with validated supply chains, traceable batch records, and established documentation processes. These requirements can support multiyear supply arrangements because manufacturers must protect the validated process used for each clinical application. Japan included 3D-printed complete denture materials in national insurance coverage in 2025 and expanded the applicable denture types in June 2026.

Shift From Prototyping to Functional Resin Parts

The additive manufacturing resins market is gaining support as industrial users shift from prototypes toward functional parts that must work consistently after printing. This transition changes purchasing priorities from basic printability toward performance under operational conditions, including fatigue, flex behavior, and dimensional reliability. Functional applications require resins with consistent mechanical properties, shelf stability, repeatable batch performance, and processing characteristics that suit the installed printer base. Formlabs launched Tough 1500 Resin in March 2025 to address fatigue and flex performance comparable with injection-molded polypropylene. The company introduced Tough 1000 Resin and an improved Tough 2000 Resin in November 2025, extending its functional materials range for assemblies that require impact resistance and improved surface quality. Production operations consume qualified resin at sustained rates and require tighter rheological control than prototyping environments, making validated formulations more valuable to users.

Expansion of Production-Grade Dental Workflows

Dental workflows are supporting wider use of the additive manufacturing resins market in clinical production because they combine repeatable part requirements with established laboratory processes. Keystone Industries and Carbon, Inc. developed FP3D, an FDA-cleared flexible partial denture resin that Carbon commercially launched in September 2025. The resin uses dual-cure chemistry to support dimensional accuracy, translucency, and patient-oriented denture applications while reducing dependence on conventional fabrication steps. Formlabs reports annual revenue above USD 250 million in 2026 and notes 4 consecutive quarters of dental portfolio growth. Japan’s insurance coverage for 3D-printed denture materials supports Mitsui Chemicals’ July 2026 integration of its dental 3D-printing operations into Sun Medical Co., Ltd. Public reimbursement can increase adoption where validated additive workflows provide a recognized clinical option and laboratories can use consistent materials.

Adoption of High-Throughput DLP and CLIP Platforms

High-throughput systems raise the resin consumption potential of the additive manufacturing resins market by allowing users to produce more qualified parts on each installed platform. Digital Light Processing (DLP) and Continuous Liquid Interface Production (CLIP) systems support faster production of functional parts than lower-throughput processes and can improve the economics of short production runs. Carbon’s Digital Light Synthesis (DLS) technology supports functional and isotropic parts for automotive, consumer, and medical uses. Stratasys expanded the Origin P3 DLP platform in April 2026 with Measurement-Based Warped Adaptive Modeling (WAM) software for automatic warping correction. The software supports electrical connectors, precision jigs, and industrial fixtures with less manual adjustment and more repeatable output. Higher printer throughput can raise annual resin demand when suppliers have platform-qualified formulations that meet the target application requirements.

High Cost of Certified Engineering and Biocompatible Resins

High certification costs constrain adoption in the additive manufacturing resins market, particularly among smaller medical and dental users who cannot spread qualification expenses across high production volumes. ISO 10993 cytotoxicity, irritation, and sensitization testing requires validated protocols, technical documentation, and controlled post-processing before a resin can serve body-contact applications. Stratasys’ Somos BioClear underwent ISO 10993-5, ISO 10993-10, and United States Pharmacopeia Class VI testing for medical device applications. Certified grades can cost 2-5 times more than standard prototyping grades, creating a clear price gap for laboratories and cost-sensitive manufacturing operations. Henkel AG & Co. KGaA pursued European Union 10/2011 food-contact requirements for Loctite 3D IND3785 after migration and extraction testing across food simulants. European compliance requirements can lengthen commercialization schedules and favor suppliers with larger regulatory teams, proven testing methods, and established quality systems.

Proprietary Printer-Resin Qualification Lock-In

Proprietary printer-resin qualification can limit material choice in the additive manufacturing resins market when approved materials are tied to a specific hardware platform. Platform-approved materials are often required to preserve warranty coverage, validated process performance, and the post-processing conditions used for certified applications. This approach protects the pricing power of integrated hardware and materials suppliers and can reduce opportunities for independent resin producers. It can also constrain users who need a certified grade unavailable in a single vendor’s catalog or require a property outside the available product range. Open material ecosystems offer an alternative where third-party suppliers can qualify materials for specific printers and end-use requirements. Adoption remains gradual because healthcare and aerospace users may avoid changes that affect service contracts, validation records, warranty conditions, and established quality procedures.

*Our forecasts treat driver/restraint impacts as directional, not additive. The impact forecasts reflect baseline growth, mix effects, and variable interactions.

Segment Analysis

By Resin Type: Photopolymer Resins Lead Both Market Share and Growth

Photopolymer resins held 56.34% of the additive manufacturing resins market share in 2025 and are projected to advance at a 6.45% CAGR through 2031. Their position reflected broad compatibility with stereolithography (SLA), DLP, and CLIP platforms used in dental, medical, and industrial applications, allowing suppliers to address multiple uses with related chemistry platforms and application-specific formulations. Thermoplastic resins served structural and high-temperature uses on fused deposition modeling (FDM) systems. These materials supported part designs where flexibility, temperature resistance, and geometry were more important than sub-50-micron resolution. Epoxy resins addressed tooling and composite lay-up mandrel applications that required dimensional stability under mechanical loading.

Polyurethane resins supported elastomeric and lattice applications across the additive manufacturing resins market because flexible components require controlled deformation after printing. Other resins included bio-based and ceramic-filled composites that addressed specialized performance requirements. Formlabs offered more than 40 SLA materials, while Stratasys supplied Somos BioClear for demanding applications. Arkema obtained International Sustainability and Carbon Certification (ISCC) PLUS certification for Sartomer sites in Chatham, Virginia, and West Chester, Pennsylvania, in April 2025. The certification enabled bio-attributed ultraviolet light-emitting diode electron beam resin solutions.

By End-Use Industry: Healthcare Drives Both Revenue and Growth Velocity

Healthcare held 35.13% of the additive manufacturing resins market share in 2025 and is projected to advance at a 6.78% CAGR through 2031. Surgical guide resins, audiology shell materials, orthodontic model compounds, and flexible denture formulations require application-specific clearances and clearly defined processing conditions. These requirements create recurring material demand after clinical workflows are validated by laboratories, clinicians, and device manufacturers. Carbon launched FP3D in September 2025 with Keystone Industries for flexible partial dentures in the United States and Canada and targeted European regulatory approvals for 2026.

The automotive industry is moving from prototyping toward functional end-use applications in the additive manufacturing resins market. Carbon and Group Lotus announced a May 2026 collaboration for a density-tuned DLS lattice car seat that replaced conventional foam construction. The aerospace and defense industry requires thermally stable and flame-retardant grades with material traceability and controlled production records. Stratasys launched ULTEM 1010 for the F3300 printer in April 2026 for composite tooling and high-temperature fixtures. Industrial manufacturing and consumer goods also use resins for jigs, fixtures, and short-run tooling, where digital production can replace conventional tooling steps. Healthcare growth is supported by insurance reimbursement in Japan and a growing range of biocompatible formulations.

Geography Analysis

North America held 38.77% of the additive manufacturing resins market share in 2025. The region had a deep installed base of production-grade DLP and SLA systems, a high concentration of FDA-cleared photopolymer materials, and digitally advanced dental laboratories. Henkel AG & Co. KGaA completed a USD 30 million expansion of its Brandon, South Dakota, facility in September 2025, doubling the site to 70,000 square feet for LOCTITE-branded adhesives and thermal management materials^{[2].Henkel AG & Co. KGaA, “Henkel Celebrates Expansion of Flagship Manufacturing Facility in Brandon,” Henkel AG & Co. KGaA, henkel.com} Europe continued to serve as a significant regional base, with Germany acting as an industrial hub.

German compliance requirements support investment in materials with advanced performance and documentation. These requirements place emphasis on traceability, predictable processing, and the ability to meet application-specific standards. Asia-Pacific is projected to advance at a 6.33% CAGR through 2031. China and India support regional revenue, while Japan, South Korea, and Taiwan support specialty resin demand. The regional mix creates different requirements for lower-cost functional grades and premium specialty formulations.

China’s oral health plan targets 80% caries treatment coverage by 2030, supporting demand for dental resins. Japan’s insurance coverage of 3D-printed denture materials began in 2025 and expanded in June 2026. Covestro AG opened a thermoplastic polyurethane site in Zhuhai, South China, with an initial annual capacity of 30,000 metric tons. South America, and Middle-East and Africa remain early-stage areas where access to certified-grade materials limits adoption. These regions have demand potential, but distribution capacity and certification costs remain significant barriers.